Cytomegalovirus (CMV) Specific Cytotoxic T Lymphocytes (CTL) When Used for Prophylaxis Against CMV in Recipients of Allogeneic, T Cell Depleted Stem Cell Transplants
Clinical trial NCT00673868 · COMPLETED
Trial details
- NCT number
- NCT00673868
- Sponsor
- Milton S. Hershey Medical Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2008-08-06
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.